Vice President, Accounting and Financial Reporting

Job Title : Vice President, Accounting and Financial Reporting

Location : Hybrid

Position Summary

We are seeking a Vice President of Accounting and Financial Reporting who will report to the Chief Financial Officer. You will focus on leading Celcuity’s external reporting processes, oversee technical accounting matters, and ensure compliance with SEC and GAAP requirements. This role oversees the Controller and related accounting functions to ensure the accuracy, transparency, and regulatory compliance of Celcuity's financial reporting. The ideal candidate will have extensive experience in SEC reporting and technical accounting within a public company.

Responsibilities

SEC Reporting

• Lead the preparation and review of all SEC filings, including 10-K, 10-Q, and other periodic filings, ensuring accuracy, completeness and compliance with regulatory requirements.
• Collaborate with internal and external auditors, legal teams, and senior management on SEC filings and disclosure requirements.
• Develop internal review processes to ensure and distribution of SEC reports and disclosures to meet strict deadlines.

Technical Accounting

Team Leadership and Development

Qualifications

About Us

Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth.

Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K / AKT / mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+ / HER2- ABC in the 1L and 2L settings. A Phase 1b / 2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going.

Notice to Recruiters / Staffing Agencies

Recruiters and staffing agencies should not contact Celcuity through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees directly.

We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file.

Celcuity’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Celcuity and such organization and will be considered unsolicited. Celcuity will not be responsible for related fees.

Celcuity is an Equal-Opportunity Employer.

Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive. For this role, the anticipated base pay range is $150,000 - $170,000. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.

#J-18808-Ljbffr